Francesca Barone
Seminars
Thursday 8th October 2026
Integration of Biomarkers & Imaging to Define Patient Response in a Phase I/II Clinical Trial
12:20 pm
- Outlining a strategy for integrating diverse data streams, from molecular biomarkers to advanced imaging, to create a unified view of patient response
- Discussing how real-time insights from biomarkers and imaging can inform dynamic adjustments to drug dosage and treatment schedules, moving beyond traditional safety metrics
- Exploring how this integrated approach can provide a more robust and evidence based foundation for making critical decisions about advancing the drug to a larger trial
